Site US10020 — Concord, North Carolina

Site US10020 is a clinical research site located in Concord, North Carolina, United States 28025.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US10020 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Prostate Cancer.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10020?

Site US10020 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10020 conducted?

Site US10020 has 1 clinical trials on record, with 1 currently active. Their work covers Prostate Cancer.

Is Site US10020 accredited by Crixeo Health?

Site US10020 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10020?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.